Chari A, Stewart AK, Russell SD, et al. Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials. Blood advances. 2018, 2(13):1633-1644. doi: 10.1182/bloodadvances.2017015545.
Advertisement
Articles by Chari A, Stewart AK, Russell SD, et al. Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials. Blood advances. 2018, 2(13):1633-1644. doi: 10.1182/bloodadvances.2017015545.
Advertisement
Latest Updated Articles
- Study Summary: Cardiovascular Safety Profile of Carfilzomib in Multiple Myeloma Clinical Trials
Published: October 18th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms
2
2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells
3
Contributor: Why Public Health Keeps Failing—and How to Fix It
4
Pricing and Insurance Networks in Outpatient Surgery Markets
5
